SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-11-056170
Filing Date
2011-03-04
Accepted
2011-03-04 15:33:31
Documents
7
Effectiveness Date
2011-03-04

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3asr.htm S-3ASR 279894
2 OPINION OF LATHAM & WATKINS, LLP dex51.htm EX-5.1 25862
3 STATEMENT REGARDING THE COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 32687
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1992
5 STATEMENT OF ELIGIBILITY ON FORM T-1 dex251.htm EX-25.1 52349
6 GRAPHIC g157004g15r42.jpg GRAPHIC 8854
7 GRAPHIC g157004g63b38.jpg GRAPHIC 7260
  Complete submission text file 0001193125-11-056170.txt   416428
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-172617 | Film No.: 11664495
SIC: 2836 Biological Products, (No Diagnostic Substances)